Service | Details | Compliance | Suppliers |
Select a relevant service
To better assist you with your request, please choose a research area provided by Sigla Sciences. In case you cannot find an exact match, simply select any service, and our concierge team will swiftly address it once your request has been submitted.
-
Health Economics and Outcomes Research (HEOR)
Evaluate data collected during drug development to maximize the value of a therapeutic product.
-
Market Access
Find general strategies and methods used to market a pharmaceutical product or device.
-
Real World Evidence (RWE) Studies
Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
-
Market Research & Business Intelligence
Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
-
Value Dossiers Development
Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.
-
Pricing Strategy
Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
-
Health Technology Assessment Submission (HTA Submission)
Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern submissions. See also AMCP and Value Dossier.
-
Marketing and Commercialization
Identify, promote and prove the value of a particular drug to key stakeholders.
-
Formulary & Reimbursement Strategy
Develop strategy and narrative to gain formulary access on insurance plans.
-
Value Based Agreements or Outcomes-Based Contracts
Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
- Load more services